Upgrade to SI Premium - Free Trial

Westlake Chemical Partners LP Announces Third Quarter 2022 Results

November 3, 2022 6:30 AM

HOUSTON--(BUSINESS WIRE)-- Westlake Chemical Partners LP (NYSE: WLKP) (the "Partnership") today reported net income attributable to the Partnership in the third quarter of 2022 of $14.8 million, or $0.42 per limited partner unit, an increase of $2.0 million compared to third quarter 2021 of $12.8 million. Volatile downstream demand lowered planned offtake, resulting in a $13.9 million buyer deficiency fee from Westlake Corporation ("Westlake"). The difference in net income for the third quarter of 2022 as compared to the third quarter of 2021 was primarily due to higher production at Westlake Chemical LP's ("OpCo") Petro 2 facility in Lake Charles, Louisiana, where production was impacted in the prior-period by a planned turnaround in the second half of 2021 and the buyer deficiency fee. These increases were partially offset by lower margins on third party ethylene sales and higher interest expense. Cash flows from operating activities in the third quarter of 2022 were $115.5 million, an increase of $16.0 million compared to third quarter 2021 cash flows from operating activities of $99.5 million due to higher net income. For the three months ended September 30, 2022, MLP distributable cash flow was $16.7 million, an increase of $3.7 million compared to third quarter 2021 MLP distributable cash flow of $13.0 million. The increase in MLP distributable cash flow and associated trailing twelve-month coverage ratio was primarily attributable to higher production and net income at OpCo.

Third quarter 2022 net income attributable to the Partnership of $14.8 million decreased by $1.6 million compared to second quarter 2022 net income of $16.4 million, primarily due to lower third-party revenues and lower production partially offset by the buyer deficiency fee. Third quarter 2022 cash flows from operating activities of $115.5 million decreased by $5.4 million compared to second quarter 2022 cash flows from operating activities of $120.9 million due to lower production and net income. Third quarter 2022 MLP distributable cash flow of $16.7 million, decreased by $2.9 million compared to second quarter 2022 MLP distributable cash flow of $19.6 million. The decrease was primarily due to lower third-party revenues and lower production partially offset by the buyer deficiency fee.

"The Partnership's performance in the third quarter of 2022 reflects the ratable and long-term strength of our market position and the protective provisions of our sales agreement with Westlake. We are well positioned to continue to deliver solid distributions as a result of the sales agreement that provides a fixed margin on 95% of our production," said Albert Chao, President and Chief Executive Officer. "As we look ahead to 2023, we remain optimistic about the ethylene market and we will continue to benefit from the insulative attributes of the agreement with Westlake. These attributes should drive strong returns and predictable cash flows to our unitholders, providing a premium value as market conditions evolve."

On October 31, 2022, the Partnership announced that the Board of Directors of Westlake Chemical Partners GP LLC had approved a quarterly distribution for the third quarter of 2022 of $0.4714 per unit to be payable on November 28, 2022 to unitholders of record as of November 10, 2022, representing the 33rd consecutive quarterly distribution to our unitholders. MLP distributable cash flow provided trailing twelve-month coverage of 1.07x the declared distributions for the third quarter of 2022, which was an increase from the trailing twelve-month coverage ratio of 1.01x at the end of the second quarter of 2022.

OpCo's Ethylene Sales Agreement with Westlake is designed to provide for stable and predictable cash flows. The agreement provides that 95% of OpCo's ethylene production is sold to Westlake for a cash margin of $0.10 per pound, net of operating costs, maintenance capital expenditures and reserves for future turnaround expenditures.

The statements in this release and the related teleconference relating to matters that are not historical facts, such as those with respect to the ability to deliver value, returns, predictable cash flows and distributions to unitholders, optimism about the ethylene market, and the expectation that strong distributions will continue and provide premium value, are forward-looking statements. These forward-looking statements are subject to significant risks and uncertainties. Actual results could differ materially, based on factors including, but not limited to, the COVID-19 pandemic and the response thereto; operating difficulties; the volume of ethylene that we are able to sell; the price at which we are able to sell ethylene; changes in the price and availability of feedstocks; changes in prevailing economic conditions; actions and commitments of Westlake Corporation; actions of third parties; inclement or hazardous weather conditions, including flooding, and the physical impacts of climate change; environmental hazards; changes in laws and regulations (or the interpretation thereof); inability to acquire or maintain necessary permits; inability to obtain necessary production equipment or replacement parts; technical difficulties or failures; labor disputes; difficulty collecting receivables; inability of our customers to take delivery; fires, explosions or other industrial accidents; our ability to borrow funds and access capital markets; and other risk factors. For more detailed information about the factors that could cause actual results to differ materially, please refer to the Partnership's Annual Report on Form 10-K for the year ended December 31, 2021, which was filed with the SEC in March 2022, and Quarterly Report on Form 10-Q for the quarter ended June 30, 2022, which was filed with the SEC in August 2022.

This release is intended to be a qualified notice under Treasury Regulation Section 1.1446-4(b). Brokers and nominees should treat one hundred percent (100.0%) of the Partnership's distributions to non-U.S. investors as being attributable to income that is effectively connected with a United States trade or business. Accordingly, the Partnership's distributions to non-U.S. investors are subject to federal income tax withholding at the highest applicable effective tax rate.

Use of Non-GAAP Financial Measures

This release makes reference to certain "non-GAAP" financial measures, such as MLP distributable cash flow and EBITDA. For this purpose, a non-GAAP financial measure is generally defined by the Securities and Exchange Commission ("SEC") as a numerical measure of a registrant's historical or future financial performance, financial position or cash flows that (1) excludes amounts, or is subject to adjustments that have the effect of excluding amounts, that are included in the most directly comparable measure calculated and presented in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") in the statement of income, balance sheet or statement of cash flows (or equivalent statements) of the registrant; or (2) includes amounts, or is subject to adjustments that have the effect of including amounts, that are excluded from the most directly comparable measure so calculated and presented. We report our financial results in accordance with U.S. GAAP, but believe that certain non-GAAP financial measures, such as MLP distributable cash flow and EBITDA, provide useful supplemental information to investors regarding the underlying business trends and performance of our ongoing operations and are useful for period-over-period comparisons of such operations. These non-GAAP financial measures should be considered as a supplement to, and not as a substitute for, or superior to, the financial measures prepared in accordance with U.S. GAAP. We define MLP distributable cash flow as distributable cash flow less distributable cash flow attributable to Westlake Corporation's noncontrolling interest in OpCo and distributions attributable to the incentive distribution rights holder. MLP distributable cash flow does not reflect changes in working capital balances. We define EBITDA as net income before interest expense, income taxes, depreciation and amortization. MLP distributable cash flow and EBITDA are non-GAAP supplemental financial measures that management and external users of our consolidated financial statements, such as industry analysts, investors, lenders and rating agencies, may use to assess our operating performance as compared to other publicly traded partnerships, our ability to incur and service debt and fund capital expenditures and the viability of acquisitions and other capital expenditure projects and the returns on investment of various investment opportunities. Reconciliations of MLP distributable cash flow to net income and to net cash provided by operating activities and of EBITDA to net income, income from operations and net cash provided by operating activities can be found in the financial schedules at the end of this press release.

Westlake Chemical Partners LP

Westlake Chemical Partners is a limited partnership formed by Westlake Corporation to operate, acquire and develop ethylene production facilities and other qualified assets. Headquartered in Houston, the Partnership owns a 22.8% interest in Westlake Chemical OpCo LP. Westlake Chemical OpCo LP's assets consist of three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana and an ethylene pipeline. For more information about Westlake Chemical Partners LP, please visit http://www.wlkpartners.com.

Westlake Chemical Partners LP Conference Call Information:

A conference call to discuss Westlake Chemical Partners' third quarter 2022 results will be held Thursday, November 3, 2022 at 1:00 PM Eastern Time (12:00 PM Central Time). To access the conference call, please register at: https://register.vevent.com/register/BIf58da988154b49dea6b2903159febb3b. A dial-in will be provided upon registration.

A replay of the conference call will be available beginning two hours after its conclusion. The conference call and replay will be available via webcast at: https://edge.media-server.com/mmc/p/jcohy5gt.

WESTLAKE CHEMICAL PARTNERS LP ("WESTLAKE PARTNERS")

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

Three Months Ended
September 30,

Nine Months Ended
September 30,

2022

2021

2022

2021

(In thousands of dollars, except per unit data)

Revenue

Net sales—Westlake Corporation ("Westlake")

$

364,273

$

247,887

$

1,020,042

$

708,646

Net co-products, ethylene and other sales—third parties

50,850

46,079

206,266

175,756

Total net sales

415,123

293,966

1,226,308

884,402

Cost of sales

324,629

218,038

947,073

589,746

Gross profit

90,494

75,928

279,235

294,656

Selling, general and administrative expenses

8,678

7,792

26,824

24,734

Income from operations

81,816

68,136

252,411

269,922

Other income (expense)

Interest expense—Westlake

(3,645

)

(2,190

)

(8,703

)

(6,650

)

Other income, net

618

24

683

52

Income before income taxes

78,789

65,970

244,391

263,324

Income tax provision (benefit)

484

(105

)

822

333

Net income

78,305

66,075

243,569

262,991

Less: Net income attributable to noncontrolling

interests in Westlake Chemical OpCo LP ("OpCo")

63,548

53,285

196,180

209,956

Net income attributable to Westlake Partners

$

14,757

$

12,790

$

47,389

$

53,035

Net income per limited partners unit attributable to

Westlake Partners (basic and diluted)

Common units

$

0.42

$

0.36

$

1.35

$

1.51

Distributions declared per unit

$

0.4714

$

0.4714

$

1.4142

$

1.4142

MLP distributable cash flow

$

16,734

$

12,977

$

55,609

$

54,760

Distributions declared

Limited partner units—publicly and privately held

$

9,947

$

9,943

$

29,828

$

29,817

Limited partner units—Westlake

6,657

6,657

19,971

19,971

Total distributions declared

$

16,604

$

16,600

$

49,799

$

49,788

EBITDA

$

111,825

$

94,746

$

344,776

$

352,804

WESTLAKE CHEMICAL PARTNERS LP

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

September 30,
2022

December 31,
2021

(In thousands of dollars)

ASSETS

Current assets

Cash and cash equivalents

$

19,468

$

17,057

Receivable under the Investment Management Agreement—Westlake

135,863

106,243

Accounts receivable, net—Westlake

98,399

142,791

Accounts receivable, net—third parties

24,675

5,825

Inventories

5,359

8,898

Prepaid expenses and other current assets

458

396

Total current assets

284,222

281,210

Property, plant and equipment, net

1,006,633

1,043,539

Other assets, net

140,311

155,949

Total assets

$

1,431,166

$

1,480,698

LIABILITIES AND EQUITY

Current liabilities (accounts payable and accrued and other liabilities)

$

77,657

$

106,796

Long-term debt payable to Westlake

399,674

399,674

Other liabilities

1,671

1,530

Total liabilities

479,002

508,000

Common unitholders—publicly and privately held

480,535

481,796

Common unitholder—Westlake

53,787

54,754

General partner—Westlake

(242,572

)

(242,572

)

Total Westlake Partners partners' capital

291,750

293,978

Noncontrolling interest in OpCo

660,414

678,720

Total equity

952,164

972,698

Total liabilities and equity

$

1,431,166

$

1,480,698

WESTLAKE CHEMICAL PARTNERS LP

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

Nine Months Ended
September 30,

2022

2021

(In thousands of dollars)

Cash flows from operating activities

Net income

$

243,569

$

262,991

Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation and amortization

91,682

82,830

Net loss on disposition and other

8,788

2,629

Other balance sheet changes

(2,877

)

38,127

Net cash provided by operating activities

341,162

386,577

Cash flows from investing activities

Additions to property, plant and equipment

(45,458

)

(38,490

)

Maturities of investments with Westlake under the Investment Management Agreement

247,000

203,000

Investments with Westlake under the Investment Management Agreement

(276,000

)

(276,000

)

Other

126

Net cash used for investing activities

(74,458

)

(111,364

)

Cash flows from financing activities

Quarterly distributions to noncontrolling interest retained in OpCo by Westlake

(214,486

)

(223,941

)

Quarterly distributions to unitholders

(49,807

)

(49,779

)

Net cash used for financing activities

(264,293

)

(273,720

)

Net increase in cash and cash equivalents

2,411

1,493

Cash and cash equivalents at beginning of period

17,057

17,154

Cash and cash equivalents at end of period

$

19,468

$

18,647

WESTLAKE CHEMICAL PARTNERS LP

RECONCILIATION OF MLP DISTRIBUTABLE CASH FLOW TO NET INCOME

AND NET CASH PROVIDED BY OPERATING ACTIVITIES

(Unaudited)

Three Months
Ended June 30,

Three Months Ended
September 30,

Nine Months Ended
September 30,

2022

2022

2021

2022

2021

(In thousands of dollars)

Net cash provided by operating activities

$

120,857

$

115,495

$

99,459

$

341,162

$

386,577

Changes in operating assets and liabilities and other

(36,418

)

(37,190

)

(33,384

)

(97,593

)

(123,586

)

Net income

84,439

78,305

66,075

243,569

262,991

Add:

Depreciation, amortization and

disposition of property, plant and

equipment

31,469

30,349

26,958

96,070

84,590

Less:

Contribution to turnaround reserves

(7,284

)

(7,323

)

(10,795

)

(21,811

)

(35,590

)

Maintenance capital expenditures

(10,372

)

(14,348

)

(15,346

)

(38,172

)

(41,433

)

Distributable cash flow attributable

to noncontrolling interest in OpCo

(78,668

)

(70,249

)

(53,915

)

(224,047

)

(215,798

)

MLP distributable cash flow

$

19,584

$

16,734

$

12,977

$

55,609

$

54,760

WESTLAKE CHEMICAL PARTNERS LP

RECONCILIATION OF EBITDA TO NET INCOME, INCOME FROM OPERATIONS AND NET CASH

PROVIDED BY OPERATING ACTIVITIES

(Unaudited)

Three Months
Ended June 30,

Three Months Ended
September 30,

Nine Months Ended
September 30,

2022

2022

2021

2022

2021

(In thousands of dollars)

Net cash provided by operating activities

$

120,857

$

115,495

$

99,459

$

341,162

$

386,577

Changes in operating assets and liabilities and other

(36,418

)

(37,190

)

(33,384

)

(97,593

)

(123,586

)

Net income

84,439

78,305

66,075

243,569

262,991

Less:

Other income, net

90

618

24

683

52

Interest expense

(2,859

)

(3,645

)

(2,190

)

(8,703

)

(6,650

)

Income tax benefit (provision)

(175

)

(484

)

105

(822

)

(333

)

Income from operations

87,383

81,816

68,136

252,411

269,922

Add:

Depreciation and amortization

31,009

29,391

26,586

91,682

82,830

Other income, net

90

618

24

683

52

EBITDA

$

118,482

$

111,825

$

94,746

$

344,776

$

352,804

Contact—(713) 585-2900

Investors—Steve Bender

Media—L. Benjamin Ederington

Source: Westlake Chemical Partners

Categories

Business Wire Press Releases

Next Articles